Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland

Joanna Smoleń-Dzirba,Magdalena Rosińska,Piotr Kruszyński,Jolanta Bratosiewicz-Wąsik,Robert D. Wojtyczka,Janusz Janiec,Bartosz Szetela,Marek Beniowski,Monika Bociąga-Jasik,Elżbieta Jabłonowska,Tomasz J. Wasik

Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland

2017

Joanna Smoleń-Dzirba
Magdalena Rosińska
Piotr Kruszyński
Jolanta Bratosiewicz-Wąsik
Robert D. Wojtyczka
Janusz Janiec
Bartosz Szetela
Marek Beniowski
Monika Bociąga-Jasik
Elżbieta Jabłonowska
Tomasz J. Wasik

Background Monitoring of drug resistance-related mutations among patients with recent HIV-1 infection offers an opportunity to describe current patterns of transmitted drug resistance (TDR) mutations.

Keywords:

Drug resistance
Protease
Diabetes mellitus
Gp41
Discovery and development of non-nucleoside reverse-transcriptase inhibitors
HIV fusion inhibitors
Medicine
Virology
Reverse transcriptase
Mutation
Enfuvirtide
Avidity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations